Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
Leukemia Research|June 30, 2015
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromesG Caocci, M T Voso, E Angelucci, et al.
Leukemia|November 14, 2013
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II TrialA Cortelezzi, M Sciumè, A M Liberati, et al.
Haematologica|June 19, 2001
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO)G Dini, R Cancedda, F Locatelli, et al.
Haematologica|March 28, 2001
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO)G Dini, R Cancedda, F Locatelli, et al.
Bone Marrow Transplantation|April 29, 2021
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysisD McLornan, D J Eikema, T Czerw, et al.
Gut|February 17, 2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsR Caprilli, M A Gassull, J C Escher, et al.
Leukemia|March 22, 2017
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring SystemM G Della Porta, C H Jackson, E P Alessandrino, et al.
European Urology Open Science|August 1, 2022
Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at SurgeryFrancesco Soria, B Pradere, R Hurle, et al.
Bone Marrow Transplantation|November 25, 2023
Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP studyA Mussetti, B Rius-Sansalvador, V Moreno, et al.
World Journal of Urology|April 18, 2019
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorM Ferro, G Di Lorenzo, M D Vartolomei, et al.
Pageof 23